STOCKWATCH: Missing the point
This article was originally published in Scrip
Executive Summary
As investors in life science stocks, and biotechnology companies in particular, suffered another week of significant losses there are still voices of denial from the analyst community that have completely missed the point of what the market is telling them. The generalist investor is selling out of biotech and nothing can stop the exit.